Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
ANGIODYNAMICS INC reported fiscal fourth quarter ended May 31, 2023 results: revenue $91.1 million, net income net loss of $21.5 million, EPS GAAP loss per share of $0.54. Guidance initiated.
- Period
- fiscal fourth quarter ended May 31, 2023
- Revenue
- $91.1 million
- Net income
- net loss of $21.5 million
- EPS
- GAAP loss per share of $0.54
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Fiscal Year 2023 Fourth Quarter Highlights • Net sales of $91.1 million increased 4.7% compared to the prior-year quarter o Med Tech net sales of $26.5 million increased 17.2% o Med Device net sales of $64.6 million increased 0.3% • Gross margin of 50.9% declined 250 basis points year over year • GAAP loss per share of $0.54, inclusive of a goodwill impairment of $14.5 million, or $0.37 per share, in connection with the transaction announced on June 8, 2023 • Adjusted earnings per share of $0.02
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
ANGIODYNAMICS INC reported fiscal year ended May 31, 2023 results: revenue $338.8 million, EPS GAAP loss per share of $1.33. Guidance initiated.
- Period
- fiscal year ended May 31, 2023
- Revenue
- $338.8 million
- EPS
- GAAP loss per share of $1.33
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Full-Year 2023 Highlights • Net sales of $338.8 million increased 7.1% year over year • Gross margin declined 100 basis points year over year to 51.4% • GAAP loss per share of $1.33 , inclusive of a goodwill impairment of $14.5 million, or $0.37 per share, in connection with the transaction announced on June 8, 2023 • Adjusted loss per share of $0.06
View on SEC.gov